Vol 3, No 5 (2014)

Table of Contents

Expert Opinion

Neurokinin-1, important but not the end piece PDF
Gerald M. Higa 321-329
Pulmonary toxicity related with chemotherapeutic agents PDF
Abid Khokar, Jeffrey Schneider, Cyril Cheriyan, Zubair Ali, Girish B. Nair 330-340
Agomelatine and the risk of hepatotoxicity PDF
Rüdiger Hardeland 341-346
Efficacy and safety of cilostazol in secondary ischemic stroke prevention PDF
Marisa McGinley, Sarkis Morales-Vidal 347-351
Efficacy and safety of lorcaserin-antiobesity effects with benefits PDF
Juliet D. Gotthardt, Nicholas T. Bello 352-357
Use and misuse of metoclopramide for treatment of gastroparesis: Current state of the art PDF
Andrew Mazulis, Ibrahim Habib, Eli D. Ehrenpreis 358-366
Cilostazol: Clinical efficacy and safety PDF
Gyung-Min Park, Seung-Whan Lee 367-373
Temsirolimus and solid tumors: Efficacy and safety data PDF
Bernard Lobato Prado, H. Veasey-Rodrigues 374-379
Nebivolol, a third generation beta-blocker PDF
John Cruickshank 380-391
Tinea capitis in adults PDF
Laura Atzori, Nicola Aste, Monica Pau 392-398
Role of yoga in health and disease PDF
Ananda Balayogi Bhavanani 399-406


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Disclaimer

Articles featured on this website are opinion pieces composed by the authors, and not necessarily those of the editors or Journal of Symptoms and Signs. While every effort is made to ensure that the content of this website is accurate, the website is provided “as is” and Journal of Symptoms and Signs makes no representations or warranties in relation to the accuracy or completeness of the information found on it. While the content of this site is provided in good faith, we do not warrant that the information will be kept up to date, be true and not misleading, or that this site will always be available for use.

Journal of Symptoms and Signs

ISSN 2309-6195